Newsroom
April 16, 2021
Dr. Sudha Seshadri, professor of neurology and director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, explains the link between neurodegenerative diseases and high cortisol levels in this Discover Magazine article. The story mentions that her research published in the journal Neurology, has shown that those with higher morning cortisol levels are more […]
April 7, 2021
In this News 4 segment, Dr. Sara Espinoza, Geriatrics, Gerontology and Palliative Medicine, explained the clinical trial PREVENTABLE, an NIH-funded study of the Barshop Institute. The study will investigate whether taking atorvastatin, a drug commonly used to lower cholesterol also called Lipitor®, can help adults age 75 and older maintain health by preventing dementia, disability […]
March 19, 2021
Dr. Amelie Ramirez, Population Health Sciences, and Dr. Carole White, School of Nursing, were interviewed in this Texas Public Radio program about Latinos being less likely to participate in research clinical trials, like COVID trials; it is critical that they do so, so that resulting treatments are effective for everyone. Listen here.
March 5, 2021
Eduardo Marques Zilli, MD, assistant professor and neurologist with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, was recently selected to take part in the 2021 America Academy of Neurology Diversity Leadership Program.
February 12, 2021
Dr. Gabriel de Erausquin, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, contributed to this Telemundo (Spanish-language) story regarding the research that he and other leading scientists from more than 30 countries are doing, supported by the Alzheimer’s Association, that is investigating the possible consequences of COVID-19 on the brain; he is currently in Argentina […]
February 10, 2021
The work of dementia researchers from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases is referenced in this opinion/commentary published in the Sun-Gazette; while it is becoming clear that the damage done by COVID-19 will have chronic consequences, the question remains as to what degree and under what form. Read the story.